MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

December 07 18:18 2022

New York, USA – December 7, 2022 – MicrobioSeq is on behalf of the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a renowned reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The company offers gene expression analysis services that identify phenotypic differences at the molecular level, provide insight into the role of differential gene expression in the microbial biological process, and facilitate the discovery of novel genes and mRNA isoforms.

Microorganisms can be used as production strains or food ingredients as they are highly stable and functional under specific conditions. For example, probiotics need to resist gastric acid in the stomach and intestines. In order to ensure the consistent performance of microbial strains, it is necessary to investigate the gene of expression in the desired physiological environment.

Microbial transcriptome sequencing technology is a single-bacteria research method that obtains transcript structure and expression information by sequencing single-colony microbial transcripts. Microorganisms will show differences in gene expression in specific habitats or periods in order to respond to environmental changes. Using the transcriptome sequencing technology, transcription information of a specific sample in a particular time and space can be effectively studied so as to identify key functional genes and solve unknowns regarding microbial functions.

Meanwhile, metatranscriptomics analyzes and measures the expression of multiple genes and functions simultaneously by detecting and quantifying mRNA transcripts. Metatranscriptomics explores the functional diversity of microbial communities in different habitats and examines microbial responses to changing environments, thus elucidating the structural and functional diversity of specific microbial communities. In addition, CD Genomics applies RNA-seq methods to detect, quantify, and compare mRNA transcript levels of a microbial strain under various conditions.

“We offer both microbial RNA-Seq based on NGS and full-length, direct RNA sequencing based on the PacBio or Oxford Nanopore platforms for gene expression analysis. We are capable of providing professional services on microbial genomics with our years of experience in microbial identification, diversity analysis, and characterization,” commented the chief scientist of CD Genomics.

Through the years, CD Genomics has become a leading provider of microbiology solutions to research institutions and biological companies. Equipped with platforms such as Illumina Hiseq/Miseq, PacBio Sequel, Oxford MinIONTM, Oxford GridIONTM, PCR-DGGE (PCR-denaturing gradient gel electrophoresis), real-time qPCR, and cloning libraries, CD Genomics is committed to ensuring accurate and thorough microbiological analysis as well as complex bioinformatics analysis pipelines through standardized laboratory methods based on these platforms.

About the MicrobioSeq Division of CD Genomics

MicrobioSeq is the microbial genomics division of CD Genomics, which is a genomics service company with a good reputation for providing reliable microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services.

Media Contact
Company Name: CD Genomics
Contact Person: Kiko Garcia
Email: Send Email
Phone: 1-631-259-7705
Country: United States
Website: https://www.cd-genomics.com